FERNANDO
ESCOBAR JIMÉNEZ
Investigador en el periodo 1989-2017
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (2)
2004
-
Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761
2003
-
A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus
Clinical Therapeutics, Vol. 25, Núm. 4, pp. 1074-1095